R1	Has_value Arg1:T1 Arg2:T2	
R2	Has_qualifier Arg1:T7 Arg2:T8	
*	OR T4 T6 T7
R3	Has_mood Arg1:T4 Arg2:T5	
*	OR T10 T11
R4	Subsumes Arg1:T13 Arg2:T14	
R5	Has_value Arg1:T12 Arg2:T13	
R6	Has_qualifier Arg1:T18 Arg2:T19	
*	OR T16 T17 T18
R7	Has_qualifier Arg1:T21 Arg2:T23	
R8	Has_mood Arg1:T21 Arg2:T22	
*	OR T25 T26
R9	AND Arg1:T25 Arg2:T24	
R10	Has_qualifier Arg1:T28 Arg2:T29	
R11	Has_mood Arg1:T30 Arg2:T31	
R12	Has_temporal Arg1:T30 Arg2:T32	
*	OR T34 T33
T1	Person 0 3	Age
T2	Value 4 15	18 or older
T3	Non-query-able 17 134	Willing and able to comply with the study procedures and provide written informed consent to participate in the study
T4	Condition 158 175	pancreatic cancer
T5	Mood 149 157	probable
T6	Condition 177 225	distal common bile duct (CBD) cholangiocarcinoma
T7	Condition 236 257	periampullary cancers
T8	Qualifier 230 235	other
T10	Condition 284 312	Biliary obstructive symptoms
T11	Condition 284 303;316 321	Biliary obstructive signs
T12	Measurement 323 338	Bilirubin level
T13	Value 339 366	at/above 100 umol per liter
T14	Value 339 347;368 377	at/above 5.8 mg/dL
T15	Condition 380 406	Distal biliary obstruction
T16	Condition 423 440	pancreatic cancer
T17	Condition 442 471	distal CBD cholangiocarcinoma
T18	Condition 481 505	periampullary malignancy
T19	Qualifier 475 480	other
T20	Condition 519 545	distal biliary obstruction
T21	Procedure 596 601	stent
T22	Mood 562 573	would allow
T23	Qualifier 619 646	at least 2cm from the hilum
T24	Condition 657 677	deemed as resectable
T25	Procedure 681 703	pancreatic protocol CT
T26	Procedure 681 700;707 710	pancreatic protocol MRI
T28	Condition 712 730	Surgical candidate
T29	Qualifier 731 759	per pancreatobiliary surgeon
T30	Procedure 797 804	Surgery
T31	Mood 805 811	intent
T32	Temporal 812 826	within 4 weeks
T33	Procedure 843 861	surgical treatment
T34	Procedure 828 838;852 861	Endoscopic treatment
